FDA advisory committee to vote on Johnson & Johnson COVID-19 booster, a day after endorsing the Moderna one

FDA advisory committee to vote on Johnson & Johnson COVID-19 booster, a day after endorsing the Moderna one
·5 min read

One day after a U.S. Food and Drug Administration advisory panel voted to endorse a booster shot of the Moderna vaccine for seniors and other at-risk groups, it will reconvene to discuss a booster shot of Johnson & Johnson's one-dose regimen and weigh in on who, if anyone, should be offered one of those.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting